Santa Ana Bio
Alameda
About Santa Ana Bio
Santa Ana Bio is a biotechnology company that leverages deep cell profiling technologies to design precision biologics in the autoimmune space. The company utilizes multi-omics platforms and antibody engineering to develop targeted therapies for patients with autoimmune and inflammatory diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $176.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2024)
- Website: santaanabio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/santa-ana-bio-5817 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.